Establishment of Shaanxi rare blood group information supply platform
10.13303/j.cjbt.issn.1004-549x.2023.10.022
- VernacularTitle:陕西省稀有血型血液信息化供应平台的建立
- Author:
Liangzi ZHANG
1
;
Qinqin ZUO
1
;
Dazhou WU
1
;
Yong ZHANG
1
;
Xiaoyue CHU
1
;
Weiwei ZHANG
1
;
Hong WANG
1
;
Juan MAO
1
;
Hua XU
1
Author Information
1. Blood Center of Shaanxi Province, Xi’an 710100, China
- Publication Type:Journal Article
- Keywords:
rare blood type;
information supply platform;
blood transfusion safety
- From:
Chinese Journal of Blood Transfusion
2023;36(10):949-952
- CountryChina
- Language:Chinese
-
Abstract:
【Objective】 To establish a rare blood group information supply platform in Shaanxi Province. 【Methods】 The rare blood group information supply platform consists of sample registration, result registration, donor files and inventory blood. The blood donation codes of voluntary blood donors were recorded for blood typing, and the antigen identification results of each blood group system were registered, all stored in the rare blood type information supply platform. When receiving an application for unusual or rare blood type missing multiple conventional antigens or a certain high-frequency antigen, the corresponding antigen negative blood donors and their blood status (in stock or not) were queried from the donor profile module of the platform, and the inventory of blood of rare blood type was monitored dynamically. 【Results】 The results showed that 5.060% (273/5 398) of rare Rh phenotype donors, 1.540‰ (51/33 010) of donors lacking multiple regular antigens, and 13 O-type donors lacking high-frequency antigens were recorded in the rare blood type information supply platform. Among them, 0.019‰ (3/158 484) of Jk(a-b-) phenotype, 0.436‰ (2/4 586) of Di(a+b-) phenotype, and 4.030‰ (8/1 983) of Fy (a-b+) phenotype were stored in the blood bank for rare blood type. 【Conclusion】 The establishment of rare blood group information supply platform can meet the urgent demand for blood of rare blood types in clinical practice and ensure the safety of blood transfusion.